Sai Life Sciences shares jump 16% post listing. Should you buy, sell or hold?

Sai Life Sciences shares surged 16% to Rs 764.4 on their BSE debut, opening at a premium of 18% over the IPO price. Analysts offer mixed advice, with some suggesting profit-booking while others recommend a long-term hold. The company's strong performance and the growing global demand for small molecule contract research and manufacturing support its potential.